Lftd Partners Inc. (LIFD): Cost of Revenue
$24.30M
Year ended 2025-12-31
$29.23M
Trailing 12 months to 2026-06-30
-12.6%
3-year compound annual growth
+48.1%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $24.30M | -1.1% | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | $24.57M | -23.0% | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | $31.91M | -12.4% | 2026-04-01, From 2023-01-01 |
| 2022-12-31 | $36.42M | +131.8% | 2025-03-31, From 2022-01-01 |
| 2021-12-31 | $15.72M | +361.2% | 2024-03-29, From 2021-01-01 |
| 2020-12-31 | $3.41M | n/a | 2023-03-21, From 2020-01-01 |
| 2019-12-31 | $0 | n/a | 2022-03-31, From 2019-01-01 |
| No annual figure between 2011-12-31 and 2019-12-31. | |||
| 2011-12-31 | $192.5K | -92.3% | 2012-03-30, From 2011-01-01 |
| 2010-12-31 | $2.51M | n/a | 2012-03-30, From 2010-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $24.30M | -1.1% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $24.05M | -0.6% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $31.61M | +50.6% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $10.21M | +15.8% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2024-12-31 | $2.60M | +420.0% |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | $14.03M | +24.8% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $10.35M | +26.3% |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $43.07M | -11.7% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $6.67M | +1.2% |
Compare LIFD, SBFM, BGM, ETST side by side · Screen every company in Pharmaceutical Preparations ↗